Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Salicylic acid 16.7% / Lactic acid 16.7% paint
1307000M0AAAWAW
|
Salicylic acid (Warts/Calluses) | Salicylic acid | Skin | 8,371 |
|
Salicylic acid 12% / Lactic acid 4% gel
1307000M0AAAVAV
|
Salicylic acid (Warts/Calluses) | Salicylic acid | Skin | 3,869 |
|
Salicylic acid 26% gel
1307000M0AABMBM
|
Salicylic acid (Warts/Calluses) | Salicylic acid | Skin | 2,823 |
|
Salicylic acid 26% solution
1307000M0AABABA
|
Salicylic acid (Warts/Calluses) | Salicylic acid | Skin | 935 |
|
Salicylic acid 16.7% / Lactic acid 15% paint
1307000M0AABYBY
|
Salicylic acid (Warts/Calluses) | Salicylic acid | Skin | 930 |
|
Salicylic acid 50% ointment
1307000M0AAAEAE
|
Salicylic acid (Warts/Calluses) | Salicylic acid | Skin | 549 |
|
Salicylic acid 40% medicated plasters
1307000M0AABSBS
|
Salicylic acid (Warts/Calluses) | Salicylic acid | Skin | 423 |
|
Salicylic acid 10% ointment in a base
1307000M0AABVBV
|
Salicylic acid (Warts/Calluses) | Salicylic acid | Skin | 159 |
|
Salicylic acid 20% ointment in a base
1307000M0AABZBZ
|
Salicylic acid (Warts/Calluses) | Salicylic acid | Skin | 76 |
|
Salicylic acid 3% / Lactic acid 3% in White soft paraffin
1307000M0AABTBT
|
Salicylic acid (Warts/Calluses) | Salicylic acid | Skin | 4 |
|
Salicylic acid 11% / Lactic acid 4% gel
1307000M0AAAXAX
|
Salicylic acid (Warts/Calluses) | Salicylic acid | Skin | 1 |
|
Salicylic acid 12.5% / Camphor 3.11% liquid
1307000M0AABLBL
|
Salicylic acid (Warts/Calluses) | Salicylic acid | Skin | 1 |
|
Salicylic acid 1% / Lactic acid 2% in Gen Unguentum M cream
1307000M0AABXBX
|
Salicylic acid (Warts/Calluses) | Salicylic acid | Skin | No data available |
|
Salicylic Acid 10% medicated plasters
1307000M0AACACA
|
Salicylic acid (Warts/Calluses) | Salicylic acid | Skin | No data available |
|
Salicylic acid 12.5% ointment
1307000M0AABPBP
|
Salicylic acid (Warts/Calluses) | Salicylic acid | Skin | No data available |
|
Salicylic acid 12% collodion
1307000M0AAAAAA
|
Salicylic acid (Warts/Calluses) | Salicylic acid | Skin | No data available |
|
Salicylic acid 17% paint
1307000M0AAAIAI
|
Salicylic acid (Warts/Calluses) | Salicylic acid | Skin | No data available |
|
Salicylic acid 25% / Podophyllum resin 20% ointment
1307000M0AAA7A7
|
Salicylic acid (Warts/Calluses) | Salicylic acid | Skin | No data available |
|
Salicylic acid 5% / Lactic acid 5% in Gen Unguentum M cream
1307000M0AABWBW
|
Salicylic acid (Warts/Calluses) | Salicylic acid | Skin | No data available |
|
Salicylic acid 5% / Lactic acid 5% in White soft paraffin
1307000M0AABUBU
|
Salicylic acid (Warts/Calluses) | Salicylic acid | Skin | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.